This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Dr. Steven Fakharzadeh, MD, PhD
Global Medical Affairs Leader Immunodermatology at Janssen
Speaker

Agenda Sessions

  • Program Update on JNJ-2113, The First and Only Investigational Targeted Oral Peptide for Psoriasis

    1:45pm